At IRCAN, we recognize the intricate relationship between cancer and aging biology. Traditionally, these two fields have been explored in isolation, yet their interconnected nature suggests a more integrated approach holds promise for groundbreaking discoveries. This realization shapes our innovative strategy, blending the expertise of both scientists and physicians to forge a cohesive understanding of the mechanisms driving cancer and aging.

As a thematic laboratory, IRCAN is dedicated to unraveling the complex links between aging and cancer. Our research spans a continuum from basic science to clinical applications, creating a multidisciplinary nexus where ideas and findings flow seamlessly across different fields. At IRCAN, projects are not only ambitious but diverse, encompassing a broad array of disciplines such as biochemistry, molecular and cellular biology, genetics, epigenetics, genomics, immunology, metabolism, pharmacology, neurology, geriatrics, and oncology.

Our work is enriched by an extensive toolkit of research models—from traditional cell cultures and organoids to innovative uses of organisms like budding yeast, corals, sea anemones, fish, and rodents. These models, along with rigorous clinical studies, are integral to our mission. They provide unique insights and foster an environment where theoretical knowledge meets practical application, driving advances in our understanding of aging and cancer. Join us on this exciting journey at IRCAN, where we strive to transform the landscape of medical research by bridging the gap between aging and cancer, promising better outcomes for future generations.